CAU
VCEL icon

Caxton Associates (UK)’s Vericel Corp VCEL Stock Holding History

Caxton Associates (UK)’s Portfolio VCEL Stock Details VCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,700
Closed -$205K – 1014
2025
Q4 		$205K Buy
+5,700
New +$209K ﹤0.01% 708

Other funds holding VCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Caxton Associates (UK)'s VCEL Position: Q1 2026 in Review

Caxton Associates (UK) sold out of Vericel Corp (VCEL) in Q1 2026, closing a stake of 5,700 shares — an estimated $205K sold.

Caxton Associates (UK) first reported a position in VCEL in Q4 2025 and held it in 1 quarter. The position peaked at $205K in Q4 2025. 279 funds tracked by Wall St. Rank hold VCEL as of Q1 2026.

  • Caxton Associates (UK) reported no remaining Vericel Corp position as of Q1 2026 after selling out during the quarter.
  • Caxton Associates (UK) sold 5,700 Vericel Corp shares in Q1 2026, an estimated $205K.
  • Caxton Associates (UK) first reported a position in Vericel Corp in Q4 2025 and held it in 1 quarter.
  • Caxton Associates (UK)'s Vericel Corp position peaked at $205K in Q4 2025.
  • 279 funds tracked by Wall St. Rank held Vericel Corp as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.